Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Catalyst Pharmaceuticals, Inc. (CPRX) had Free Cash Flow per Share of $1.29 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$148.39M |
|
$52.78M |
|
$22.65M |
|
$125.74M |
|
$82.12M |
|
$66.27M |
|
$4.77M |
|
$71.03M |
|
$71.03M |
|
$52.78M |
|
$52.78M |
|
$52.78M |
|
$52.78M |
|
$66.27M |
|
$75.68M |
|
122.60M |
|
127.09M |
|
$0.43 |
|
$0.42 |
|
| Balance Sheet Financials | |
$852.45M |
|
$1.08M |
|
$199.15M |
|
$1.05B |
|
$128.74M |
|
-- |
|
$2.62M |
|
$131.36M |
|
$920.25M |
|
$791.61M |
|
$920.25M |
|
123.27M |
|
| Cash Flow Statement Financials | |
$163.78M |
|
$-0.03M |
|
$8.59M |
|
$517.55M |
|
$689.89M |
|
$172.34M |
|
$19.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
84.73% |
|
44.66% |
|
44.66% |
|
-- |
|
47.87% |
|
35.57% |
|
$163.75M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.81 |
|
1.39 |
|
64.54 |
|
5.74% |
|
6.67% |
|
5.02% |
|
5.74% |
|
$7.47 |
|
|
Free Cash Flow per Share |
$1.29 |
$1.29 |
|